Literature DB >> 15681902

Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease.

H Worth Boyce1, Michael R Bakheet.   

Abstract

Saliva is produced by the major salivary glands (parotid, submandibular, and sublingual), as well as several smaller glands. Salivary flow can be altered by multiple entities. There is much written regarding xerostomia ("dry mouth"), the condition related to inhibited or decreased salivary flow. This condition is widely recognized in certain systemic diseases, particularly Sjögren syndrome, diabetes mellitus, after anticholinergic, antihistamine, and decongestant medications, as well as states of enhanced sympathetic drive, such as anxiety or emotional disturbances and various other psychosocial conditions. On the other hand, sialorrhea or ptyalism, the condition of increased salivary flow, is rarely discussed in the clinical literature. Sialorrhea can occur with various neurologic disorders, infections, the secretory phase of the menstrual cycle, heavy metal poisoning, Wilson disease, Angelman syndrome, as well as a relatively unknown condition called idiopathic paroxysmal sialorrhea. Normal salivation may be altered by drugs (such as clozapine, risperidone, nitrazepam, lithium, and bethanecol) that have a cholinergic effect that induces sialorrhea. This report focuses on sialorrhea as it relates to disorders of the oropharynx and esophagus. The patient typically recognizes a problem with excessive "foamy mucus" but does not understand its origin. Infections and obstruction are the most common oropharyngeal causes. Increased salivary flow occurs as a typically subtle manifestation of gastroesophageal reflux disease. This occurrence is referred to as water brash. Idiopathic achalasia and megaesophagus due to the parasite Trypanosoma cruzi are regularly associated with sialorrhea. Esophageal obstruction (foreign body, cancer, or stricture formation), infection, and nasogastric intubation are the more common conditions associated with the symptomatic sequelae of sialorrhea. Sialorrhea-related respiratory and pulmonary complications are greatest in those with a diminished sensation of salivary flow and hypopharyngeal retention. Extremes of age, the chronically debilitated, or those in chronic care facilities, especially associated with cerebrovascular accidents and esophageal cancer, typically comprise this population. For the patient with an intact awareness of saliva, sialorrhea can present with significant social stigmas. Occult drooling or regular oral evacuation into a tissue or "spit cup" is socially incapacitating. This report provides a review of the physiology, pathogenesis, clinical manifestations, and therapeutic options for sialorrhea. Physicians and other healthcare professionals should recognize the importance of sialorrhea as a possible indicator or complication of a variety of disease states of the oropharynx and esophagus as well as its impact on the patient's physical and social quality of life.

Entities:  

Mesh:

Year:  2005        PMID: 15681902

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  12 in total

Review 1.  Clozapine-induced sialorrhea: pathophysiology and management strategies.

Authors:  Samir Kumar Praharaj; Manu Arora; Sachin Gandotra
Journal:  Psychopharmacology (Berl)       Date:  2006-03-03       Impact factor: 4.530

Review 2.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

Review 3.  Drooling in Parkinson's disease: a review.

Authors:  Prachaya Srivanitchapoom; Sanjay Pandey; Mark Hallett
Journal:  Parkinsonism Relat Disord       Date:  2014-08-27       Impact factor: 4.891

4.  Management of drooling in disabled patients with scopolamine patches.

Authors:  Abigail Mato; Jacobo Limeres; Inmaculada Tomás; Maria Muñoz; Concepción Abuín; Javier F Feijoo; Pedro Diz
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

5.  Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia.

Authors:  Mehmet Karakoc; Mehmet Ilker Yon; Gul Yalcin Cakmakli; Ersin Kasim Ulusoy; Aydin Gulunay; Nese Oztekin; Fikri Ak
Journal:  Neurol Sci       Date:  2016-09-09       Impact factor: 3.307

6.  Prevalence of Xerostomia in Patients Referred to Shiraz Dental School, Shiraz, Iran during 2006-2013.

Authors:  Jannan Ghapanchi; Fahimeh Rezazadeh; Erfan Fakhraee; Aisa Zamani
Journal:  Iran J Public Health       Date:  2016-12       Impact factor: 1.429

Review 7.  Associations between tooth wear and dental sleep disorders: A narrative overview.

Authors:  Peter Wetselaar; Daniele Manfredini; Jari Ahlberg; Anders Johansson; Ghizlane Aarab; Chryssa E Papagianni; Marisol Reyes Sevilla; Michail Koutris; Frank Lobbezoo
Journal:  J Oral Rehabil       Date:  2019-05-12       Impact factor: 3.837

Review 8.  Artificial Saliva for Therapeutic Management of Xerostomia: A Narrative Review.

Authors:  Hajer Ayed Alhejoury; Lina Fouad Mogharbel; Mohammed Ahmed Al-Qadhi; Suzan Sulaiman Shamlan; Amal Fuad Alturki; Wafaa Mohammed Babatin; Renad Abdualrahman Mohammed Alaishan; Fawaz Pullishery
Journal:  J Pharm Bioallied Sci       Date:  2021-11-10

Review 9.  The chronic gastrointestinal manifestations of Chagas disease.

Authors:  Nilce Mitiko Matsuda; Steven M Miller; Paulo R Barbosa Evora
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  pH salivary analysis of subjects suffering from Sjögren's syndrome and laryngopharyngeal reflux.

Authors:  Marco Antonio Dos Anjos Corvo; Claudia Alessandra Eckley; Bianca Maria Liquidato; Gustavo Leão Castilho; Cibelle Nunes de Arruda
Journal:  Braz J Otorhinolaryngol       Date:  2012-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.